Selected article for: "acute lymphopenia myocardial dysfunction and admission ali"
Author: Lin Fu; Jun Fei; Shen Xu; Hui-Xian Xiang; Ying Xiang; Zhu-Xia Tan; Meng-Die Li; Fang-Fang Liu; Ying Li; Ming-Feng Han; Xiu-Yong Li; Hui Zhao; De-Xiang Xu
Title: Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study
  • Document date: 2020_4_6
    • ID: 5gbjdr0u_28
    Snippet: The present study aimed to analyze SARS-CoV-2-induced ALI, its association with death risk and the prognosis after discharge. The major findings of this study include: (1) ALI is more common in the critically ill COVID-19 patients; (2) Accumulating data demonstrated that SARS-CoV-2 infection caused multiple organ injuries, including myocardial dysfunction, lymphopenia and even acute renal These results provide evidence that ALI on admission is as.....
    Document: The present study aimed to analyze SARS-CoV-2-induced ALI, its association with death risk and the prognosis after discharge. The major findings of this study include: (1) ALI is more common in the critically ill COVID-19 patients; (2) Accumulating data demonstrated that SARS-CoV-2 infection caused multiple organ injuries, including myocardial dysfunction, lymphopenia and even acute renal These results provide evidence that ALI on admission is associated with the severity of COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • acute lymphopenia myocardial dysfunction and present study: 1
    • critically ill patient and death risk: 1
    • critically ill patient and myocardial dysfunction: 1, 2, 3
    • critically ill patient and organ injury: 1, 2
    • critically ill patient and patient severity: 1
    • critically ill patient and present study: 1, 2, 3
    • critically ill patient and renal result: 1
    • death risk and discharge prognosis: 1, 2, 3
    • death risk and discharge prognosis death risk association: 1, 2
    • death risk and multiple organ injury: 1
    • death risk and myocardial dysfunction: 1, 2, 3
    • death risk and organ injury: 1, 2, 3, 4, 5, 6, 7
    • death risk and patient severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • death risk and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death risk and renal result: 1, 2, 3
    • death risk and SARS analyze: 1, 2, 3
    • death risk and SARS analyze aim: 1
    • death risk association and SARS analyze: 1
    • death risk association and SARS analyze aim: 1